3SBio Inc. (TRSBF)
OTCMKTS · Delayed Price · Currency is USD
4.740
+0.840 (21.54%)
Jul 29, 2025, 3:15 PM EDT
3SBio Market Cap
3SBio has a market cap or net worth of $10.08 billion as of July 29, 2025. Its market cap has increased by 418.20% in one year.
Market Cap
10.08B
Enterprise Value
10.06B
Revenue
1.25B
Ranking
n/a
PE Ratio
35.21
Stock Price
$4.74
Market Cap Chart
Since June 11, 2015, 3SBio's market cap has increased from 2.92B to 10.08B, an increase of 244.89%. That is a compound annual growth rate of 12.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2025 | 10.09B | 447.30% |
| Dec 31, 2024 | 1.84B | -20.16% |
| Dec 29, 2023 | 2.31B | -11.06% |
| Dec 30, 2022 | 2.60B | 23.47% |
| Dec 31, 2021 | 2.10B | -9.35% |
| Dec 31, 2020 | 2.32B | -29.58% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 789.71M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 590.95M |
| Glass House Brands | 435.80M |
| Northwest Biotherapeutics | 379.00M |
| CytoDyn | 371.09M |